Synthesis of antisense oligonucleotide - Peptide conjugate targeting to GLUT-1 in HepG-2 and MCF-7 cells

Bioconjugate Chemistry

Volumn 13, Issue 3, 2002, Pages 525-529

  Chen, Chang Po ^a   Li, Xiao Xu ^a   Zhang, Liang Ren ^a   Min, Ji Mei ^a   Chan, Judy Yuet Wah ^b   Fung, Kwok Pui ^b   Wang, Sheng Qi ^c   Zhang, Li He ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROLIFERATION; OLIGONUCLEOTIDES; RNA;

ANTISENSE OLIGONUCLEOTIDES; ANTISENSE RNA; CANCER CELLS; CONDITION; MCF-7 CELLS; P-HYDROXYBENZOIC ACID; PEPTIDE MIMICS; SIGNAL PEPTIDE; SIMPLE++;

PEPTIDES;

MINK CELL FOCUS-FORMING VIRUS;

4 HYDROXYBENZOIC ACID; 4 HYDROXYBENZOIC ACID ESTER; 4-HYDROXYBENZOIC ACID; ANTISENSE OLIGONUCLEOTIDE; CROSS LINKING REAGENT; GLUCOSE TRANSPORTER; GLUCOSE TRANSPORTER 1; MESSENGER RNA; NUCLEOTIDE; PEPTIDE; SLC2A1 PROTEIN, HUMAN;

ARTICLE; CELL CULTURE; CELL DIVISION; CHEMISTRY; DOSE RESPONSE; DRUG EFFECT; FEMALE; GENETIC TRANSFECTION; GENETICS; HUMAN; METABOLISM; NORTHERN BLOTTING; SYNTHESIS; WESTERN BLOTTING;

BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL DIVISION; CROSS-LINKING REAGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLUCOSE TRANSPORTER TYPE 1; HUMANS; MONOSACCHARIDE TRANSPORT PROTEINS; OLIGONUCLEOTIDES, ANTISENSE; PARABENS; PEPTIDES; RNA, MESSENGER; THIONUCLEOTIDES; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0036000133     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc015540f     Document Type: Article

References (43)

1. Antisense oligonucleotides: A new therapeutic principle
2. Gene inhibition using antisense oligonucleotides
3. Oligonucleotide therapy
4. Transport of oligonucleotides across natural and model membrane
5. Modification of antisense phosphodiester oligodeoxynucleotides by a 5′-cholesteryl moiety increases cellular association and improved efficacy
6. Synthesis and physical properties of anti-HIV antisense oligonucleotides bearing terminal lipophilic groups
7. Modulation of human prorenin gene expression by antisense oligonucleotides in transfected CHO cells
8. The synthesis and biological activities of oligodeoxynucleotides that are covalently linked to psoralen at their 5′ ends
9. An acridine-linked oligodeoxynucleotide targeted to the common 5′ end of try-panosome mRNAs kills cultured parasites
10. A new class of antivirals: Antisense oligonucleotides combined with a hydrophobic substituent effectively inhibit influenza virus reproduction and synthesis of virus-specific proteins in MDCK cells
11. Short modified antisense oligonucleotides directed against Ha-ras point mutation induce selective cleavage of the mRNA and inhibit T 24 cells proliferation
12. Synthesis of defined peptide-oligonucleotide hybrids containing a nuclear transport signal sequence
13. Preparation and characterization of antisense oligonucleotide-peptide hybrids containing viral fusion peptides
14. Stepwise solid-phase synthesis of oligonucleotide-peptide hybrids
15. Routine preparation of third oligonucleotides: Application to the synthesis of oligonucleotide-peptide hybrids
16. Membrane insertion and lateral mobility of synthetic amphilic signal peptides in lipid model membranes
17. Penetration of the signal sequence of Escherichia coli PhoE protein into phospholipid model membranes leads to lipid-specific changes in signal peptide structure and alterations of lipid organization
18. Increases in mRNA levels of glucose transporters types 1 and 3 in Ehrlich ascites tumor cells during tumor development
19. Inhibition of glucose transporter gene expression by antisense nucleic acids in HL-60 leukemia cells
20. Synthesis of spin labeled conjugate of peptide and peptide nucleic acid
21. Facile preparation of nuclease resistant 3′ modified oligodeoxynucleotides
22. Towards a general method for the stepwise solid-phase synthesis of peptide-oligonucleotide conjugates
23. Preparation and applications of peptide ollgonucleotide conjugates
24. The synthesis of peptide-oligonucleotide conjugates by a fragment coupling approach
25. Synthesis of oligonucleotide-peptide conjugates containing a KDEL signal sequence
26. On-line solid-phase synthesis of oligonucleotide-peptide hybrid using silica supports
27. The solid-phase synthesis of oligonucleotides containing a 3′-peptide moiety
28. Solid phase synthesis of directly linked peptide-oligonucleotide hybrids using standard synthesis protocols
29. Facile preparation of 3′ oligonucleotide-peptide conjugates
30. Use of Nα-Fmoc-cystein (S-thiobutyl) derivatized oligodeoxynucleotides for the preparation of oligodeoxynucleotide-peptide hybrid molecules
31. Synthesis of oligoarginine-oligonucleotide conjugates and oligoarginine-bridged oligonucleotide pairs
32. A new solid-phase synthesis of oligonucleotides 3′-conjugated with peptides
33. Convergent solution-phase synthesis of a nucleotide using a protected oligonucleotide
34. Quantitative monitoring of solid-phase peptide synthesis by the ninhydrin reaction
35. Astudy of some variables in tetrazolium dye (MTT) based assay for cell growth and chemosensitivity
36. Covalent interaction of proteins and nucleic acids: Synthetic and natural nucleotide-peptides
37. Chemoenzymatic synthesis of nucleopeptide
38. Synthesis of a naturally occurring nucleopeptide fragment via a phosphotriester approach
39. Synthesis of a nucleopeptide fragment from poliovirus genome
40. Signal sequence: The limits of variation
41. The signal peptide
42. Inhibition of nuclear translocation factor NF-κB by a synthetic peptide containing a cell membrane-permeable motif and nuclear translocation sequence
43. Cytosolic and nuclear delivery of oligonucleotides mediated by an amphiphilic anionic peptide